Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
Azita H. Talasaz, Parham Sadeghipour, Luis Ortega‐Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig J. Beavers, John Fanikos, John W. Eikelboom, Deborah Siegal, Manuel Monréal, David Jiménez, Muthiah Vaduganathan, Lana A. Castellucci, Adam Cuker, Geoffrey D. Barnes, Jean M. Connors, Eric A. Secemsky, Benjamín Van Tassell, Raffaele De Caterina, Jacob E. Kurlander, Ali Aminian, Gregory Piazza, Samuel Z. Goldhaber, Lisa K. Moores, Saskia Middeldorp, Ajay J. Kirtane, Mitchell S.V. Elkind, Dominick J. Angiolillo, Stavros Konstantinides, Professor Gregory Lip, Gregg W. Stone, Mary Cushman, Harlan M. Krumholz, Roxana Mehran, Deepak L. Bhatt, Behnood Bikdeli (2024). Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. , 21(8), DOI: https://doi.org/10.1038/s41569-024-01003-3.
Article59 days agoInvestigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, Isaac Dreyfus, Hessam Kakavand, Hamid Ariannejad, Aakriti Gupta, Mahesh V. Madhavan, Benjamín Van Tassell, David Jiménez, Manuel Monréal, Muthiah Vaduganathan, John Fanikos, Dave L. Dixon, Gregory Piazza, Sahil A. Parikh, Deepak L. Bhatt, Professor Gregory Lip, Gregg W. Stone, Harlan M. Krumholz, Peter Libby, Samuel Z. Goldhaber, Behnood Bikdeli (2021). Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19. , 78(16), DOI: https://doi.org/10.1016/j.jacc.2021.08.021.
Article59 days agoLipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, Isaac Dreyfus, Hessam Kakavand, Hamid Ariannejad, Aakriti Gupta, Mahesh V. Madhavan, Benjamín W. Van Tassell, David González Jiménez, Manuel Monréal, Muthiah Vaduganathan, John Fanikos, Dave L. Dixon, Gregory Piazza, Sahil A. Parikh, Deepak L. Bhatt, Professor Gregory Lip, Gregg W. Stone, Harlan M. Krumholz, Peter Libby, Samuel Z. Goldhaber, Behnood Bikdeli (2021). Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials. , DOI: https://doi.org/10.1101/2021.05.03.21256468.
Preprint59 days agoLipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, Isaac Dreyfus, Hessam Kakavand, Hamid Ariannejad, Aakriti Gupta, Mahesh V. Madhavan, Benjamín W. Van Tassell, David González Jiménez, Manuel Monréal, Muthiah Vaduganathan, John Fanikos, Dave L. Dixon, Gregory Piazza, Sahil A. Parikh, Deepak L. Bhatt, Professor Gregory Lip, Gregg W. Stone, Harlan M. Krumholz, Peter Libby, Samuel Z. Goldhaber, Behnood Bikdeli (2021). Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials. , DOI: https://doi.org/10.1101/2021.05.03.21256468.
Preprint59 days agoEstimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes
Priya Vart, Muthiah Vaduganathan, Niels Jongs, Giuseppe Remuzzi, David C. Wheeler, Finnian R. Mc Causland, Glenn M. Chertow, Hiddo J.L. Heerspink (2022). Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes. , 17(12), DOI: https://doi.org/10.2215/cjn.08900722.
Article59 days ago